Persistence of hepatitis B virus DNA after reduction of viral replication in serum and liver. 1992

J Molina, and J Bartolomé, and G Moraleda, and M Ruiz-Moreno, and M J Rua, and A Moreno, and V Carreño
Department of Gastroenterology, Fundación Jiménez Díaz, Madrid, Spain.

Liver and serum samples from 67 children with hepatitis B chronic infection, whether or not treated with recombinant interferon, were analyzed for the presence of hepatitis B virus DNA. After follow-up, 44/67 (66%) still had serum and liver viral DNA; 23/67 (34%) were negative for serum hepatitis B virus DNA. Of the 23 children in the latter group, liver biopsy was available in 21 and viral DNA was not detected by Southern-blot in 20. In the remaining patient, viral DNA was in an episomal nonreplicative form. Polymerase chain reaction was performed in the 21 serum samples negative for viral DNA by conventional techniques and in the 21 liver samples (20 negative for hepatitis B virus DNA and 1 with episomal nonreplicative form). All liver samples resulted in a positive reaction to viral DNA by this technique. Serum viral DNA by polymerase chain reaction was detected in 15/21 (71%) of these patients. The mean of alanine aminotransferase values was similar in patients with or without hepatitis B virus DNA in serum by polymerase chain reaction. In summary, in the majority of the patients who respond to the therapy, there is a persistence of viral replication detected by polymerase chain reaction. This fact explains the persistence of serum HBsAg in these patients. However, more studies are necessary to determine the meaning of the presence of hepatitis B virus DNA that is only detectable by polymerase chain reaction.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B

Related Publications

J Molina, and J Bartolomé, and G Moraleda, and M Ruiz-Moreno, and M J Rua, and A Moreno, and V Carreño
July 1991, Hepatology (Baltimore, Md.),
J Molina, and J Bartolomé, and G Moraleda, and M Ruiz-Moreno, and M J Rua, and A Moreno, and V Carreño
August 1997, Journal of hepatology,
J Molina, and J Bartolomé, and G Moraleda, and M Ruiz-Moreno, and M J Rua, and A Moreno, and V Carreño
January 1983, Hepatology (Baltimore, Md.),
J Molina, and J Bartolomé, and G Moraleda, and M Ruiz-Moreno, and M J Rua, and A Moreno, and V Carreño
January 1994, The Journal of clinical investigation,
J Molina, and J Bartolomé, and G Moraleda, and M Ruiz-Moreno, and M J Rua, and A Moreno, and V Carreño
August 1994, The Journal of clinical investigation,
J Molina, and J Bartolomé, and G Moraleda, and M Ruiz-Moreno, and M J Rua, and A Moreno, and V Carreño
February 1990, Liver,
J Molina, and J Bartolomé, and G Moraleda, and M Ruiz-Moreno, and M J Rua, and A Moreno, and V Carreño
December 1993, Hepatology (Baltimore, Md.),
J Molina, and J Bartolomé, and G Moraleda, and M Ruiz-Moreno, and M J Rua, and A Moreno, and V Carreño
April 2008, Transplantation,
J Molina, and J Bartolomé, and G Moraleda, and M Ruiz-Moreno, and M J Rua, and A Moreno, and V Carreño
January 2001, Annals of surgery,
J Molina, and J Bartolomé, and G Moraleda, and M Ruiz-Moreno, and M J Rua, and A Moreno, and V Carreño
June 1989, Annals of internal medicine,
Copied contents to your clipboard!